{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:17:42Z","timestamp":1785521862294,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.clinthera.2009.08.014","type":"journal-article","created":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T08:47:47Z","timestamp":1254818867000},"page":"1754-1764","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"31","author":[{"given":"Mesut","family":"Ogrendik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.08.014_bib1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"Lee","year":"2001","journal-title":"Lancet."},{"key":"10.1016\/j.clinthera.2009.08.014_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.1780390412","article-title":"Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies","volume":"39","author":"Fries","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinthera.2009.08.014_bib3","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/art.1780401221","article-title":"Risk for periodontal disease in patients with longstanding rheumatoid arthritis","volume":"40","author":"K\u00e4sser","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinthera.2009.08.014_bib4","first-page":"1650","article-title":"Adult periodontitis as a model for rheumatoid arthritis (with emphasis on treatment strategies)","volume":"26","author":"Greenwald","year":"1999","journal-title":"J Rheumatol."},{"key":"10.1016\/j.clinthera.2009.08.014_bib5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1902\/jop.2001.72.6.779","article-title":"Relationship between rheumatoid arthritis and periodontitis","volume":"72","author":"Mercado","year":"2001","journal-title":"J Periodontol"},{"key":"10.1016\/j.clinthera.2009.08.014_bib6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2005.036913","article-title":"The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction","volume":"65","author":"Marotte","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.clinthera.2009.08.014_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-051X.1999.260203.x","article-title":"A \u201ccase control\u201d study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodonti-tis. Identification of types and subtypes using molecular biology (PCR.SSO)","volume":"26","author":"Bonfil","year":"1999","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.clinthera.2009.08.014_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/ard.42.3.292","article-title":"The association between rheumatoid arthritis and the HLA antigen DR4","volume":"42","author":"Gran","year":"1983","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.clinthera.2009.08.014_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/RHU.0b013e3180690616","article-title":"Control of periodontal infection reduces the severity of active rheumatoid arthritis","volume":"13","author":"Al-Katma","year":"2007","journal-title":"J Clin Rheumatol."},{"key":"10.1016\/j.clinthera.2009.08.014_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1128\/CDLI.10.6.1043-1050.2003","article-title":"Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients","volume":"10","author":"Moen","year":"2003","journal-title":"Clin Diagn Lab Immunol."},{"key":"10.1016\/j.clinthera.2009.08.014_bib11","first-page":"2","article-title":"Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis","volume":"7","author":"Ogrendik","year":"2005","journal-title":"MedGenMed."},{"key":"10.1016\/j.clinthera.2009.08.014_bib12","first-page":"656","article-title":"Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs","volume":"24","author":"Moen","year":"2006","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.clinthera.2009.08.014_bib13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/art.1780361104","article-title":"Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study","volume":"36","author":"Hannonen","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinthera.2009.08.014_bib14","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/1529-0131(200110)44:10<2235::AID-ART385>3.0.CO;2-A","article-title":"Treatment of early seropositive rheumatoid arthritis: A two-year, double-blind comparison of mino-cycline and hydroxychloroquine","volume":"44","author":"O\u2019Dell","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinthera.2009.08.014_bib15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/rheumatology\/kel020","article-title":"Treatment of rheumatoid arthritis with ornidazole. A randomized, double-blind, placebo-controlled study","volume":"45","author":"Ogrendik","year":"2006","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.clinthera.2009.08.014_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8553(21)00421-0","article-title":"Sulfasalazine therapy in inflammatory bowel disease","volume":"18","author":"Das","year":"1989","journal-title":"Gastroenterol Clin North Am."},{"key":"10.1016\/j.clinthera.2009.08.014_bib17","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/ard.2003.017749","article-title":"Use of minocycline in rheumatoid arthritis: A district general hospital experience","volume":"63","author":"Suresh","year":"2004","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.clinthera.2009.08.014_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cden.2005.03.001","article-title":"Etiology and pathogenesis of periodontal diseases","volume":"49","author":"Tatakis","year":"2005","journal-title":"Dent Clin North Am."},{"key":"10.1016\/j.clinthera.2009.08.014_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1006\/phrs.2001.0884","article-title":"Anti-inflammatory capabilities of macrolides","volume":"44","author":"Zalewska-Kaszubska","year":"2001","journal-title":"Pharmacol Res."},{"key":"10.1016\/j.clinthera.2009.08.014_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(24)35272-3","article-title":"Anti-inflammatory activity of mac-rolide antibiotics","volume":"292","author":"Ianaro","year":"2000","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1016\/j.clinthera.2009.08.014_bib21","series-title":"Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases","first-page":"2561","article-title":"Bacteroides, Prevotella, Porphyromonas and Fusobacterium species (and other medically important anaerobic gram-negative bacilli)","author":"Lorber","year":"2000"},{"key":"10.1016\/j.clinthera.2009.08.014_bib22","first-page":"1765","article-title":"Roxithromycin specifically inhibits development of collagen induced arthritis and production of proin-flammatory cytokines by human T cells and macrophages","volume":"32","author":"Urasaki","year":"2005","journal-title":"J Rheumatol."},{"key":"10.1016\/j.clinthera.2009.08.014_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1183\/09031936.04.00057104","article-title":"Suppression of matrix me-talloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro","volume":"23","author":"Kanai","year":"2004","journal-title":"Eur Respir J."},{"key":"10.1016\/j.clinthera.2009.08.014_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein","volume":"337","author":"Moreland","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.08.014_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/000163501750266765","article-title":"Cytokines in periodontal disease: Where to from here?","volume":"59","author":"Seymour","year":"2001","journal-title":"Acta Odontol Scand."},{"key":"10.1016\/j.clinthera.2009.08.014_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1600-0765.1997.tb00535.x","article-title":"Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria","volume":"32","author":"Yoshimura","year":"1997","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.clinthera.2009.08.014_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1902\/jop.1995.66.2.139","article-title":"Bacterial-stimulated cytokine production of peripheral mononuclear cells from patients of various periodontitis categories","volume":"66","author":"Kjeldsen","year":"1995","journal-title":"J Periodontol"},{"key":"10.1016\/j.clinthera.2009.08.014_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02592303","article-title":"Human monocytes and gingival fibroblasts release tumor necrosis factor-alpha, interleukin-1 alpha and interleukin-6 in response to particulate and soluble fractions of Prevotella melaninogenica and Fusobacterium nucleatum","volume":"23","author":"Rossano","year":"1993","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.clinthera.2009.08.014_bib29","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/art.10427","article-title":"Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with metho-trexate: A six-month, double-blind, randomized, dose-ranging study","volume":"46","author":"Furst","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"158","key":"10.1016\/j.clinthera.2009.08.014_bib30","first-page":"9","article-title":"Revising the Declaration of Helsinki","year":"2000","journal-title":"Bull Med Ethics"},{"key":"10.1016\/j.clinthera.2009.08.014_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2009.08.014_bib32","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/000456329703400601","article-title":"Effects of drugs on clinical laboratory tests","volume":"34","author":"Young","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.clinthera.2009.08.014_bib33","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/art.1780261107","article-title":"Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire","volume":"26","author":"Pincus","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2009.08.014_bib34","first-page":"789","article-title":"The dimensions of health outcomes: The health assessment question- naire, disability and pain scales","volume":"9","author":"Fries","year":"1982","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2009.08.014_bib35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780360601","article-title":"The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials","volume":"36","author":"Felson","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2009.08.014_bib36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"Preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2009.08.014_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2009.08.014_bib39","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/rheumatology\/keh297","article-title":"Remission in rheumatoid arthritis: Agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria","volume":"43","author":"Fransen","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2009.08.014_bib40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/ard.62.5.419","article-title":"Applying low disease activity criteria using the DAS28 to assess stability in patients with rheumatoid arthritis","volume":"62","author":"Vrijhoef","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2009.08.014_bib41","series-title":"Application of Biostatistics [in Turkish]","author":"Sumbuloglu","year":"1991"},{"key":"10.1016\/j.clinthera.2009.08.014_bib42","doi-asserted-by":"crossref","first-page":"14014","DOI":"10.1073\/pnas.93.24.14014","article-title":"A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases","volume":"93","author":"Amin","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinthera.2009.08.014_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-122-2-199501150-00001","article-title":"Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial","volume":"122","author":"Tilley","year":"1995","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.clinthera.2009.08.014_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/art.1780370505","article-title":"Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial","volume":"37","author":"Kloppenburg","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2009.08.014_bib45","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/art.1780400510","article-title":"Treatment of early rheumatoid arthritis with minocycline or placebo: Results of a randomized, double-blind, placebo-controlled trial","volume":"40","author":"O\u2019Dell","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2009.08.014_bib46","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/1529-0131(199908)42:8<1691::AID-ANR18>3.0.CO;2-S","article-title":"Treatment of early seropositive rheumatoid arthritis with minocycline: Four-year followup of a double-blind, placebo-controlled trial","volume":"42","author":"O\u2019Dell","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2009.08.014_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1749-6632.1994.tb24734.x","article-title":"Treatment of destructive arthritic disorders with MMP inhibitors. Potential role of tetracyclines","volume":"732","author":"Greenwald","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinthera.2009.08.014_bib48","first-page":"28","article-title":"Tetracyclines inhibit human synovial collagenase in vivo and in vitro","volume":"14","author":"Greenwald","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2009.08.014_bib49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1749-6632.1994.tb24772.x","article-title":"Low dose doxycycline inhibits pyridinoline excretion in selected patients with rheumatoid arthritis","volume":"732","author":"Greenwald","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinthera.2009.08.014_bib50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002960050030","article-title":"Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis","volume":"17","author":"Nordstr\u00f6m","year":"1998","journal-title":"Rheumatol Int"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809002975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809002975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T15:46:28Z","timestamp":1739375188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809002975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0149291809002975"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.08.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}